According to a study, patients are frequently prescribed broad-spectrum antibiotics instead of narrowly tailored antibiotics, which would be more optimized to treat them.
One antimicrobial agent commonly used in the management of burns is silver sulfadiazine.
Results of a recent preclinical study provide proof of concept that an mRNA HIV vaccine is safe, immunogenic, and induces CD4–T-cell responses.
The approval was based on safety and efficacy data from 30 participants in 2 open-label, single-arm studies that received 1 to 3 infusions of donislecel.
A recent study highlights the significant frequency of the adverse effect.
One antimicrobial agent commonly used in the management of burns is silver sulfadiazine.
Molnupiravir is an oral antiviral for the treatment of mild to moderate COVID-19 in adults at high risk of severe disease.
Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
Pharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.
Paying for these new therapies, that may be curative for patients, remains a challenge.
Cefepime/enmetazobactam was granted a 5-year exclusivity extension under GAIN Act legislation.
Epic research suggests that like COVID-19, flu and other viral pneumonias can result in long-term symptoms like fatigue and brain fog. Why that might be is open question.
Does anxiety justify an exemption from vaccine mandates among health care workers?
The FDA's decision represents a landmark approval of a tumor-derived cellular therapy in a solid tumor cancer.
The shift to value-based care in the U.S. has been slow in coming, in large part because providers have continued to cling to the traditional “fee for service” healthcare model that historically has worked well for them.
Ease patients’ concerns by being well versed in the safety profiles of each vaccine.
Stipulations of the settlements include data reporting, annual training, and an independent compliance officer.
Often referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.
In a world rich with diversity, pharmacists need to understand how varied backgrounds and special needs can impact a patient’s decisions in managing their health and medication protocols.
Pharmacy leaders have leveraged their experience, their role in interdisciplinary teams, and technology to quickly reinvent approaches to manage long-standing issues exacerbated by the pandemic.
Unfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.
Compared to only 10% of primary and subspecialty visits, 34.5% of mental health visits took place via video in August 2023.
Now more than ever, 30 million Americans living with a range of 7000 rare or orphan diseases require a high level of therapy adherence support.
Pharmacists can work with their patients to address concerns about vaccinations.
Belantamab mafodotin-blmf is now indicated for adult patients with relapsed or refractory myeloma who have received at least 4 prior therapies.
Paying for these new therapies, that may be curative for patients, remains a challenge.
Pharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.
An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
Several institutions have published guidance on how to treat patients hospitalized with COVID-19.